News

US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
FDA to revise labeling of ADHD medication to indicate weight loss risk
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
US FDA to revise label of ADHD stimulants to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...
MedPage Today3d
Some ADHD Meds Can Cause Significant Weight Loss in Young Kids, FDA Warns
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
Independent Journal Review1dOpinion
SHERI FEW: It’s Time To Make Our Children Healthy Again, Starting With ADHD Reform
When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...
MPR2d
FDA: Weight Loss Risk in Younger ADHD Patients on Extended-Release Stimulants
Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...
Becker's Hospital Review4d
FDA revises ADHD medication label to note weight loss risk
The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...
Medscape4d
Telehealth vs In-Person ADHD Prescribing: Which is Safest?
Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.
Verywell Health on MSN9d
When ADHD Medication Side Effects Get in the Way—and What You Can Do
Medications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...
US FDA to revise label of ADHD medications to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...
KSL4d
FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...